SUMO Protease
產(chǎn)品描述（Product Details）
SUMO Protease is a recombinant form of Saccharomyces cerevisiae protease produced in Escherichia coli. SUMO protease can recognize the SUMO tertiary structure and cleave it, has high specificity, and there would be no amino acid residues. This product contains His-tag which can be removed by Ni2+ affinity chromatography resin.
應(yīng)用說明（Application）
Remove SUMO-tag in any recombinant SUMO fusion protein.
單位定義（Unit Definition）
One unit of SUMO Protease cleaves ≥ 85% of 2 μg control substrate in 1 h at 30℃.
純度（Purity）
>95% as determined by SDS-PAGE.
酶活（Enzyme Activity）
>10 U/μL
內(nèi)毒素（Endotoxin）
Less than 0.2 EU per μg by the LAL method.
制劑（Formulation）
Supplied as 0.2 μm filtered solution in 250 mM NaCl, pH 8.0 with glycerol as protectant.
Contact us for customized product form or formulation.
運輸（Shipping）
This product is supplied and shipped with blue ice, please inquire the shipping cost.
存儲（Storage）
This product is stable after storage at:
The product MUST be stored at -20°C or lower upon receipt.
-20°C for 3 months under sterile conditions.
關(guān)鍵字： SUMO;SUMO蛋白酶;SUMO Protease;ACRO;百普賽斯;
百普賽斯集團ACROBiosystems Group（股票代碼：301080）是成立于2010年的跨國生物科技公司，是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團業(yè)務(wù)遍布全球，橫跨亞洲、北美洲、歐洲，在中國、美國、瑞士等12個城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計服務(wù)客戶超6000家，與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關(guān)系。集團旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。